60 research outputs found
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.
Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.
Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection
Big Data: Issues, Challenges, Tools and Good Practices
Abstract-Big data is defined as large amount of data which requires new technologies and architectures so that it becomes possible to extract value from it by capturing and analysis process. Due to such large size of data it becomes very difficult to perform effective analysis using the existing traditional techniques. Big data due to its various properties like volume, velocity, variety, variability, value and complexity put forward many challenges. Since Big data is a recent upcoming technology in the market which can bring huge benefits to the business organizations, it becomes necessary that various challenges and issues associated in bringing and adapting to this technology are brought into light. This paper introduces the Big data technology along with its importance in the modern world and existing projects which are effective and important in changing the concept of science into big science and society too. The various challenges and issues in adapting and accepting Big data technology, its tools (Hadoop) are also discussed in detail along with the problems Hadoop is facing. The paper concludes with the Good Big data practices to be followed
Highly Stable Nanocrystal Engineered Palladium Decorated Cuprous Oxide Photocathode for Hydrogen Generation
The solution plasma synthesis, characterisation, and antibacterial activities of dispersed CuO nanoparticles
Visible light driven heterojunction photocatalyst of cuo-cu2o thin films for photocatalytic degradation of organic pollutants
10.3390/nano9071011Nanomaterials97101
Evaluation of solar-driven photocatalytic activity of thermal treated TiO 2 under various atmospheres
10.3390/nano9020163Nanomaterials9216
Recommended from our members
Imaging of lower extremity infections: predisposing conditions, atypical infections, mimics, and differentiating features.
Imaging evaluation for lower extremity infections can be complicated, especially in the setting of underlying conditions and with atypical infections. Predisposing conditions are discussed, including diabetes mellitus, peripheral arterial disease, neuropathic arthropathy, and intravenous drug abuse, as well as differentiating features of infectious versus non-infectious disease. Atypical infections such as viral, mycobacterial, fungal, and parasitic infections and their imaging features are also reviewed. Potential mimics of lower extremity infection including chronic nonbacterial osteomyelitis, foreign body granuloma, gout, inflammatory arthropathies, lymphedema, and Morel-Lavallée lesions, and their differentiating features are also explored
Recommended from our members
Lower extremity infections: Essential anatomy and multimodality imaging findings
Abstract:
In modern practice, imaging plays an integral role in the diagnosis, evaluation of extent, and treatment planning for lower extremity infections. This review will illustrate the relevant compartment anatomy of the lower extremities and highlight the role of plain radiographs, CT, US, MRI, and nuclear medicine in the diagnostic workup. The imaging features of cellulitis, abscess and phlegmon, necrotizing soft tissue infection, pyomyositis, infectious tenosynovitis, septic arthritis, and osteomyelitis are reviewed. Differentiating features from noninfectious causes of swelling and edema are discussed
Real-time slicing algorithm for Stereolithography (STL) CAD model applied in additive manufacturing industry
- …